Neck Carcinoma — Trials

Neck Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,419 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 464
Recruiting: 240
Ph III recruiting: 63
Growth YoY: +3.1%
Industry share: 9%
Top sponsor: Sun Yat-sen University
Termination share: 31.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (128)

clinicaltrialsPublishedShowing 101–150 of 591 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04171622	Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer	active not recruiting	Phase 2	25	M.D. Anderson Cancer CenterOTHER	1	Aug 10, 2026	clinicaltrials
NCT04623801	Laser Ablation of Papillary Thyroid Microcarcinoma	active not recruiting	Phase 2	10	Memorial Sloan Kettering Cancer CenterOTHER	1	Aug 10, 2026	clinicaltrials